Herbert Leinert

667 total citations
17 papers, 579 citations indexed

About

Herbert Leinert is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Herbert Leinert has authored 17 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Herbert Leinert's work include Chemical Synthesis and Analysis (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). Herbert Leinert is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). Herbert Leinert collaborates with scholars based in Germany, United States and Switzerland. Herbert Leinert's co-authors include Harald Zilch, Alfred Mertens, Thomas S. van der Poll, Wolfgang von der Saal, Frieder W. Lichtenthaler, Hans Seidel, Wolfgang Kampe, Ulrike Leser, Wolfgang Schaefer and Frank Grams and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Helvetica Chimica Acta.

In The Last Decade

Herbert Leinert

17 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Leinert Germany 10 367 190 111 95 76 17 579
Masahiro Fuji Japan 13 607 1.7× 267 1.4× 110 1.0× 136 1.4× 136 1.8× 22 949
Wolfgang von der Saal Germany 16 357 1.0× 423 2.2× 101 0.9× 113 1.2× 57 0.8× 35 959
Bonnie J. Bowdon United States 15 187 0.5× 320 1.7× 139 1.3× 131 1.4× 98 1.3× 28 696
Weir‐Torn Jiaang Taiwan 17 277 0.8× 273 1.4× 297 2.7× 52 0.5× 82 1.1× 41 812
Marc Lang Switzerland 12 225 0.6× 307 1.6× 156 1.4× 39 0.4× 22 0.3× 26 544
Hiromu Habashita Japan 19 737 2.0× 555 2.9× 122 1.1× 117 1.2× 40 0.5× 45 1.2k
Jeffrey W. Corbett United States 15 609 1.7× 357 1.9× 41 0.4× 152 1.6× 26 0.3× 22 887
Ryuichi Kiyama Japan 10 190 0.5× 332 1.7× 72 0.6× 171 1.8× 63 0.8× 15 584
Masahiro Ikejiri Japan 11 246 0.7× 182 1.0× 111 1.0× 48 0.5× 146 1.9× 24 521
Marc Labroli United States 11 548 1.5× 382 2.0× 161 1.5× 94 1.0× 28 0.4× 19 943

Countries citing papers authored by Herbert Leinert

Since Specialization
Citations

This map shows the geographic impact of Herbert Leinert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Leinert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Leinert more than expected).

Fields of papers citing papers by Herbert Leinert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Leinert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Leinert. The network helps show where Herbert Leinert may publish in the future.

Co-authorship network of co-authors of Herbert Leinert

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Leinert. A scholar is included among the top collaborators of Herbert Leinert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Leinert. Herbert Leinert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Grams, Frank, Hans Brandstetter, S. D’Alò, et al.. (2001). Pyrimidine-2,4,6-triones: A new effective and selective class of matrix metalloproteinase inhibitors (vol 382, pg 1278, 2001). Biological Chemistry. 382(12). 1739–1739. 2 indexed citations
2.
Grams, Frank, Hans Brandstetter, S. D’Alò, et al.. (2001). Pyrimidine-2,4,6-Triones: A New Effective and Selective Class of Matrix Metalloproteinase Inhibitors. Biological Chemistry. 382(8). 1277–85. 122 indexed citations
3.
Dickhaut, Joachim, et al.. (1999). Improved Procedures For Large Scale Preparation Of 6- and 7-Oxy-Substituted Isoquinolines and A Convenient Work-Up Protocol For Titanium Supported Reactions. Synthetic Communications. 29(9). 1617–1625. 11 indexed citations
4.
Weber, Irene T., Richard Neidlein, Wolfgang von der Saal, et al.. (1998). Diarylsulfonamides as selective, non-peptidic thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(13). 1613–1618. 9 indexed citations
5.
Grams, Frank, et al.. (1998). Tetrahydro-isoquinoline-Based Factor Xa Inhibitors. Journal of Medicinal Chemistry. 41(25). 4983–4994. 31 indexed citations
6.
Saal, Wolfgang von der, et al.. (1997). ChemInform Abstract: Derivatives of 4‐Aminopyridine as Selective Thrombin Inhibitors.. ChemInform. 28(39). 4 indexed citations
7.
Saal, Wolfgang von der, et al.. (1997). DERIVATIVES OF 4-AMINO-PYRIDINE AS SELECTIVE THROMBIN INHIBITORS. Bioorganic & Medicinal Chemistry Letters. 7(10). 1283–1288. 26 indexed citations
8.
Neidlein, Richard, et al.. (1997). A Short Synthesis of the Factor‐Xa Inhibitor DX‐9065a using palladium‐catalyzed key steps. Helvetica Chimica Acta. 80(3). 892–896. 9 indexed citations
9.
Schäfer, Wolfgang, Herbert Leinert, Alfred Mertens, et al.. (1993). Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and x-ray structure investigations. Journal of Medicinal Chemistry. 36(6). 726–732. 112 indexed citations
10.
Mertens, Alfred, Harald Zilch, Wolfgang Schaefer, et al.. (1993). Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity. Journal of Medicinal Chemistry. 36(17). 2526–2535. 190 indexed citations
11.
Lichtenthaler, Frieder W. & Herbert Leinert. (1968). Hydroxymethyl‐verzweigte Cyclanole durch Dialdehyd‐Cyclisierung mit 2‐Nitro‐äthanol. Chemische Berichte. 101(5). 1815–1818. 8 indexed citations
12.
Lichtenthaler, Frieder W., et al.. (1968). Nitromethan‐Kondensation mit Dialdehyden, XIII. Zum sterischen Verlauf der Cyclisierung aliphatischer 1.5‐Dialdehyde mit Nitromethylen‐Verbindungen. Chemische Berichte. 101(5). 1819–1836. 15 indexed citations
13.
Lichtenthaler, Frieder W., Herbert Leinert, & Tetsuo Suami. (1967). Eine einfache Synthese von Streptamin und Actinamin. Chemische Berichte. 100(7). 2383–2388. 15 indexed citations
14.
Lichtenthaler, Frieder W., Herbert Leinert, & Tetsuo Suami. (1967). A Simple Synthesis of Streptamine and Actinamine. Angewandte Chemie International Edition in English. 6(3). 254–254. 1 indexed citations
15.
Lichtenthaler, Frieder W., Herbert Leinert, & Tetsuo Suami. (1967). Eine einfache Synthese von Streptamin und Actinamin. Angewandte Chemie. 79(5). 239–240. 2 indexed citations
16.
Lichtenthaler, Frieder W. & Herbert Leinert. (1966). NMR‐Studien an Zuckern und Cyclanolen, II. cis‐Inosatriamin‐(1.3.5). Chemische Berichte. 99(3). 903–907. 15 indexed citations
17.
Lichtenthaler, Frieder W., et al.. (1966). Notizen: Synthese verzweigter Nitro- und Aminocyclanole. Zeitschrift für Naturforschung B. 21(10). 1004–1004. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026